Prestige Consumer Healthcare (NYSE:PBH) Releases Quarterly Earnings Results, Hits Estimates

Prestige Consumer Healthcare (NYSE:PBH) announced its quarterly earnings data on Thursday. The company reported $1.09 EPS for the quarter, meeting the consensus estimate of $1.09, Briefing.com reports. The company had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue for the quarter was down .9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.07 EPS. Prestige Consumer Healthcare updated its FY 2025 guidance to 4.460-4.460 EPS and its FY25 guidance to $4.40 to $4.46 EPS.

Prestige Consumer Healthcare Stock Performance

Shares of PBH opened at $80.37 on Friday. The firm has a market capitalization of $3.98 billion, a P/E ratio of 19.55, a PEG ratio of 2.19 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. Prestige Consumer Healthcare has a one year low of $56.61 and a one year high of $81.25. The business has a fifty day moving average of $72.55 and a 200 day moving average of $69.84.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PBH. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price target (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson upped their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.